Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

The Effect of a Digital Storytelling Program on Fall Among Community-Dwelling Older Adults

1. Juni 2026 aktualisiert von: Gizem Deniz Büyüksoy, Kirsehir Ahi Evran Universitesi

The Effect of a Digital Storytelling Program Based on Pender's Health Promotion Model on Fall Behaviors, Fear of Falling, and Self-Efficacy Among Community-Dwelling Older Adults

This study aims to examine fall behaviors, fear of falling, and self-efficacy levels in older adults living at home through a digital storytelling program based on Pender's Health Promotion Model, and to evaluate the effect of this program on these variables. Research hypotheses:

H1.1: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the number of falls among the elderly.

H1.2: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the risk of falls among the elderly.

H1.3: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the fear of falling among the elderly.

H1.4: The Digital Storytelling Program based on Pender's Health Promotion Model affects the total score of the Falling Behaviors Scale for the Elderly (FBS) among the elderly.

The general population of the study consisted of 80 individuals aged 65 and over registered at family health centers in Avanos district of Nevşehir province. The sample of the study was calculated as 80 people in the analysis performed using the "G. Power-3.1" program with 95% power, 0.05 margin of error and 0.82 effect size. The effect of safe movement and walking program on reducing fear of falling in elderly individuals living in nursing homes. In the study, 40 people were assigned to each group using stratified randomization method.

Inclusion criteria:

Literate, Living at home, 65 years and older, Having internet access, Able to use communication tools such as computers, tablets or smartphones, Able to communicate verbally and visually, Not having physical conditions or diseases that would prevent exercise (Stroke, Parkinson's, uncontrolled arrhythmia, serious heart disease-aortic stenosis, angina, severe musculoskeletal disease, knee and hip replacement in the last 6 months). (being bedridden),

Agreeing to participate in the study. Exclusion criteria:

Bedridden, Visually impaired, Moderate to severe cognitive impairment (Mini Mental State Test - MMD <24).

Studienübersicht

Status

Aktiv, nicht rekrutierend

Bedingungen

Intervention / Behandlung

Studientyp

Interventionell

Einschreibung (Geschätzt)

80

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

  • Türkei (türkiye)
    • Kırşehir
      • Kırşehir, Kırşehir, Türkei (türkiye), 40000
        • Kırşehir Ahi Evran University

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Participants must be literate,
  • Live at home,
  • 65 years of age or older,
  • Have internet access,
  • Able to use communication tools such as computers, tablets or smartphones,
  • Able to communicate verbally and visually,
  • Not have any physical condition or illness that would prevent them from exercising (Stroke, Parkinson's, uncontrolled arrhythmia, serious heart disease - aortic stenosis, angina, severe musculoskeletal disease, having had knee or hip replacement surgery in the last 6 months),
  • Agree to participate in the study.

Exclusion Criteria:

  • Bedridden,
  • Visually impaired,
  • Moderate to severe cognitive impairment (Mini Mental State Test - MMD <24)

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Verhütung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Doppelt

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Kein Eingriff: Kontrollgruppe
Aktiver Komparator: Intervention Group
'Digital Storytelling Program Based on Pender's Health Promotion Model on Fall Behaviors, Fear of Falling, and Self-Efficacy'
Verhalten: Digital Storytelling Program Based on Pender's Health Promotion Model on Fall Behaviors, Fear of Falling, and Self-Efficacy

Pre-intervention: Elderly individuals meeting the inclusion and exclusion criteria will be administered an introductory information form, the Fear of Falls Scale, and the Fall Behaviors Scale for the Elderly.

Intervention implementation: Elderly individuals in the experimental group will be shown digital stories prepared within the framework of Pender's Health Promotion Model-Based Digital Storytelling Program, focusing on Individual Characteristics and Experiences, Behavior-Specific Concepts and Effects, and Behavioral Outcomes. Post-intervention: Immediately after the six-week intervention and three months after its completion, the Fear of Falls Scale and the Fall Behaviors Scale for the Elderly will be collected through face-to-face interviews with individuals.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Fear of Falling Scale
Zeitfenster: From enrollment to the end of treatment at 12 weeks.
The "Fear of Falling Scale" is used to assess a person's fear of falling while performing daily activities and developed by Tinetti et al. (1990). The scale, consisting of 10 items, has a Cronbach's alpha coefficient of 0.71 in the original study. The Turkish version, validated and proven reliable by Erdem and Emel (2004). The scale items inquire whether individuals experience fear of falling while performing activities such as "bathing, reaching into a cupboard to get an item, walking in the garden, answering the door or phone, sitting down and standing up from a chair, dressing and undressing, getting in and out of bed, doing chores in their room, and simple shopping." For each question, individuals receive "1 point for Yes" if they experience fear of falling and "0 points for No" if they do not. An increase in the average fear of falling score indicates an increased fear of falling while performing daily life activities.
From enrollment to the end of treatment at 12 weeks.
Self-Efficacy/Competence Scale
Zeitfenster: From enrollment to the end of treatment at 12 weeks
It was developed and revised by Sherer et al. (63) in 1982. Its reliability and validity in Turkish was established by Gözüm and Aksayan (9) in 1999. The Cronbach Alpha value is 0.81, and the test-retest reliability was found to be 0.92. The scale consists of 23 items and four sub-factors (behavior initiation, behavior completion, behavior maintenance, and overcoming obstacles). A minimum score of 23 and a maximum score of 115 are obtained from the scale. A high total score indicates a high perception of self-efficacy/competence. It is a 5-point Likert-type scale. It consists of options ranging from "Does not describe me at all" (1) to "Describes me very well" (5). However, items 2, 4, 5, 6, 7, 10, 11, 12, 14, 16, 17, 18, 20, and 22 are scored in the opposite direction.
From enrollment to the end of treatment at 12 weeks
Fall Behavior Scale for the Elderly
Zeitfenster: From enrollment to the end of treatment at 12 weeks
Fall Behavior Scale for the Elderly: Developed by Clemson et al. (2003), this scale consists of 30 items and 10 sub-dimensions. Based on self-report, the scale aims to identify the behaviors and awareness that older adults exhibit to protect themselves from potential falls. The items in the scale inquire about activities related to home life, lighting and vision, shoe use, outdoor activities, and daily life. Each item is scored from 1 to 4 on a 4-point Likert scale. "Never" is worth 1 point, while the others are worth 2 points each for "occasionally," 3 points for "usually," and 4 points for "always." The lowest and highest possible scores for the total scale and its subscales range from 1 to 4. Higher scores indicate safe/protective behaviors related to falls, while lower scores indicate risky behaviors. The sub-dimensions of the scale are as follows: The scale consists of the following items: Cognitive Adaptation (6 items), Mobility (5 items), Avoidance (5 items), Awareness (4 items
From enrollment to the end of treatment at 12 weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Kirsehir Ahi Evran Universitesi

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. April 2026

Primärer Abschluss (Geschätzt)

30. Mai 2026

Studienabschluss (Geschätzt)

30. Juni 2026

Studienanmeldedaten

Zuerst eingereicht

22. Mai 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

1. Juni 2026

Zuerst gepostet (Tatsächlich)

5. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

1. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Andere Studien-ID-Nummern

  • 2025.12.19

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Art der unterstützenden IPD-Freigabeinformationen

  • ANALYTIC_CODE

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Gesundheitsförderung

Suchen Sie nach ähnlichen Studien

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

CROs by country

CROs in Bulgaria

Bedingungen

Seltene Krankheiten

Drogeninterventionen

Nahrungsergänzungsmittel

Sponsor / Mitarbeiter

Standorte

Abonnieren